IMMUNOSHAPE is a Marie Sklodowska Curie European Training Network that brings together 14 leading European partners providing multidisciplinary and multisectorial training in biomedical glycoscience and its industrial applications to a new generation of young scientists.

IMMUNOSHAPE, as a major EU-Horizon 2020 funded programme, implements an intersectorial training programme in a transnational network between the academic and the industrial partners in the fields of biomedical glycoscience. The new trained generation of scientists will be capable of combining state of the art synthesis and screening technology to develop new lead structures for highly selective glycan based multivalent immunotherapeutics for the treatment of cancer, autoimmune diseases and allergy.


Skip to toolbar